Literature DB >> 2465274

Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies.

K J Kim1, W N Burnette, R D Sublett, C R Manclark, J G Kenimer.   

Abstract

To identify the neutralizing epitopes on the S1 subunit (A promoter) of pertussis toxin, we characterized anti-S1 monoclonal antibodies (MAbs) X2X5, 3CX4, and 6FX1. We confirmed by immunoblot analysis that these MAbs bind to the S1 subunit and not to the B oligomer of pertussis toxin and that they recognize different epitopes by a competitive binding enzyme-linked immunosorbent assay. These MAbs had differential abilities to neutralize the lymphocytosis-promoting factor activity of pertussis toxin in mice: 3CX4 and 6FX1 had partial neutralizing abilities, while MAb X2X5 had none. With these MAbs, the epitopes on the S1 subunit were examined by using trypsinized S1 peptides, recombinant truncated S1 molecules, and synthetic peptides. The non-neutralizing MAb X2X5 bound in immunoblots to tryptic peptides of various sizes as small as 1.5 kilodaltons; the neutralizing MAbs 3CX4 and 6FX1 bound only to a 24-kilodalton tryptic peptide band. Immunoblot studies with recombinant truncated S1 molecules demonstrated that amino acid residues 7 to 14 and 15 to 26 play an important role in the binding of neutralizing MAbs and the non-neutralizing MAb, respectively. The binding of these MAbs was not dependent upon the presence of C-terminal amino acid residues 188 to 234. To further define B-cell epitopes, the binding of the MAbs we tested to synthetic peptides representing the entire S1 subunit were examined. Neutralizing MAbs 3CX4 and 6FX1 bound to none of these peptides, further suggesting that these MAbs recognize conformational epitopes. The non-neutralizing MAb X2X5 bound to peptides 11 to 26 and 16 to 30, demonstrating that the major antigenic determinant recognized by this MAb is a linear epitope located within residues 16 to 26.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2465274      PMCID: PMC313203          DOI: 10.1128/iai.57.3.944-950.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.

Authors:  M Pittman
Journal:  Rev Infect Dis       Date:  1979 May-Jun

2.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

3.  Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.

Authors:  Y Sato; K Izumiya; H Sato; J L Cowell; C R Manclark
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

Review 4.  Bordetella pertussis toxins.

Authors:  A C Wardlaw; R Parton
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

5.  Distinction of epitopes by monoclonal antibodies.

Authors:  C Stähli; V Miggiano; J Stocker; T Staehelin; P Häring; B Takács
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model.

Authors:  M Tamura; K Nogimori; S Murai; M Yajima; K Ito; T Katada; M Ui; S Ishii
Journal:  Biochemistry       Date:  1982-10-26       Impact factor: 3.162

7.  Identification of the predominant substrate for ADP-ribosylation by islet activating protein.

Authors:  G M Bokoch; T Katada; J K Northup; E L Hewlett; A G Gilman
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

8.  Monoclonal antibodies as probes of tetanus toxin structure and function.

Authors:  J G Kenimer; W H Habig; M C Hardegree
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

9.  A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells.

Authors:  M Tamura; K Nogimori; M Yajima; K Ase; M Ui
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

10.  ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity.

Authors:  T Katada; M Ui
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

View more
  17 in total

1.  Importance of holotoxin assembly in Ptl-mediated secretion of pertussis toxin from Bordetella pertussis.

Authors:  K M Farizo; T Huang; D L Burns
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion.

Authors:  Karen M Farizo; Stefanie Fiddner; Anissa M Cheung; Drusilla L Burns
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  Analysis of subassemblies of pertussis toxin subunits in vivo and their interaction with the ptl transport apparatus.

Authors:  Drusilla L Burns; Stefanie Fiddner; Anissa M Cheung; Anita Verma
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

4.  Analysis of relative levels of production of pertussis toxin subunits and Ptl proteins in Bordetella pertussis.

Authors:  Anissa M Cheung; Karen M Farizo; Drusilla L Burns
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

5.  Comparison of pertussis toxin (PT)-neutralizing activities and mouse-protective activities of anti-PT mouse monoclonal antibodies.

Authors:  H Sato; Y Sato; I Ohishi
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Monoclonal antibodies that inhibit ADP-ribosyltransferase but not NAD-glycohydrolase activity of pertussis toxin.

Authors:  H R Kaslow; J D Schlotterbeck; J G Kenimer
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

7.  Molecular characterization of an operon required for pertussis toxin secretion.

Authors:  A A Weiss; F D Johnson; D L Burns
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

8.  Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit.

Authors:  T D Bartley; D W Whiteley; V L Mar; D L Burns; W N Burnette
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 9.  Progress towards recombinant anti-infective antibodies.

Authors:  Jennifer C Pai; Jamie N Sutherland; Jennifer A Maynard
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-01

10.  Identification of human T-cell epitopes on the S4 subunit of pertussis toxin.

Authors:  J W Petersen; A Holm; P H Ibsen; K Hasløv; C Capiau; I Heron
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.